BIONOSTRA is a biotechnology company performing breakthrough technology for
the development of biologic vaccines and gene therapy.
The Company uses the many advances made in the fields of molecular biology,
structural virology, genomics and organic chemistry to build up a novel pipeline
of vaccine candidates designed to address therapeutic needs in the field of
infectious diseases for its application in animal and human health.
Our technology is based on the large scale production of nanometric particles
known as VLPs (virus like particles). The most advanced application of this
technology is the production of viral vector derived vaccines for human and
BIONOSTRA has developed a pipeline of different vaccines that are currently
under clinical or preclinical trials for its application on animal or human